CC-486 is safe and well-tolerated as maintenance therapy in elderly patients (>= 75 years) with acute myeloid leukemia (AML) in first remission following induction chemotherapy: Results from the phase III QUAZAR AML-001 trial.-MedSci.cn

CC-486 is safe and well-tolerated as maintenance therapy in elderly patients (>= 75 years) with acute myeloid leukemia (AML) in first remission following induction chemotherapy: Results from the phase III QUAZAR AML-001 trial.

Ravandi, F; Wei, A; Dohner, H; Dombret, H; Ossenkoppele, GJ; Pfeilstocker, M; Thol, F; Feldman, G; Voso, MT; Marlton, P; Harvey, M; Santini, V; Fianchi, L; Candoni, A; La Torre, I; Skikne, B; Kumar, K; Dong, Q; Beach, CL; Roboz, GJ

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

科室
- - 订阅+
  - 更多科室
工具
服务